Development of a First-in-Class RIPK1 Degrader to Enhance Antitumor Immunity.
Wang J, Lu D, Yu X, Qi X, Lin H, Holloman BL, Jin F, Xu L, Ding L, Peng W, Wang M, Chen X.
Wang J, et al. Among authors: qi x.
Res Sq [Preprint]. 2024 Apr 8:rs.3.rs-4156736. doi: 10.21203/rs.3.rs-4156736/v1.
Res Sq. 2024.
PMID: 38659866
Free PMC article.
Preprint.